Emyria Ltd Cash Flow Conversion Efficiency
Emyria Ltd cash flow conversion efficiency. Based on the latest financial reports, Emyria Ltd (EMD) has a cash flow conversion efficiency ratio of -0.316x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.67 Million ≈ $-1.18 Million USD) by net assets (AU$5.31 Million ≈ $3.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Emyria Ltd (2018–2025)
Cash flow conversion efficiency of Emyria Ltd from 2018 to 2025. This chart illustrates how Emyria Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Emyria Ltd for real-time trading data and today's change.
Emyria Ltd Cash Flow Conversion Ratio Explained
Emyria Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Emyria Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Emyria Ltd ranked by their cash flow conversion efficiency. Also see how much is Emyria Ltd worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Evergreen Fibreboard Bhd
KLSE:5101
|
-0.008x |
|
Cannindah Resources Ltd
AU:CAE
|
-0.041x |
|
Ziga Innovation Public Company Limited
BK:ZIGA
|
-0.012x |
|
Vikas Lifecare Limited
NSE:VIKASLIFE
|
0.003x |
|
Greenidge Generation Holdings Inc
NASDAQ:GREE
|
-0.002x |
|
OPG POWER VENTURES PLC
F:OPB
|
N/A |
|
Pudjiadi & Sons Tbk
JK:PNSE
|
0.115x |
|
Poolia AB (publ)
ST:POOL-B
|
0.096x |
Annual Cash Flow Conversion Efficiency for Emyria Ltd (2018–2025)
The table below shows the annual cash flow conversion efficiency of Emyria Ltd from 2018 to 2025. Review cash generation quality of Emyria Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$5.31 Million ≈ $3.75 Million |
AU$-2.70 Million ≈ $-1.91 Million |
-0.510x | +71.14% |
| 2024-06-30 | AU$2.43 Million ≈ $1.72 Million |
AU$-4.28 Million ≈ $-3.03 Million |
-1.767x | -218.22% |
| 2023-06-30 | AU$6.79 Million ≈ $4.81 Million |
AU$-3.77 Million ≈ $-2.67 Million |
-0.555x | +35.34% |
| 2022-06-30 | AU$6.32 Million ≈ $4.47 Million |
AU$-5.43 Million ≈ $-3.84 Million |
-0.859x | -56.53% |
| 2021-06-30 | AU$7.18 Million ≈ $5.08 Million |
AU$-3.94 Million ≈ $-2.79 Million |
-0.549x | +53.40% |
| 2020-06-30 | AU$3.78 Million ≈ $2.68 Million |
AU$-4.45 Million ≈ $-3.15 Million |
-1.177x | +77.33% |
| 2019-06-30 | AU$499.54K ≈ $353.46K |
AU$-2.59 Million ≈ $-1.83 Million |
-5.191x | -69937.67% |
| 2018-06-30 | AU$2.81 Million ≈ $1.99 Million |
AU$-20.82K ≈ $-14.73K |
-0.007x | -- |
About Emyria Ltd
Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services, Clinical Services, and corporate segments. It provides therapy programs for post-traumatic stress disorder (PTSD) and treatment-resistant depression. The company also develops ultra-pure CBD capsules (EMD-RX7, and EMD-… Read more